What Limits Oxygen Transfer When Polydimethylsiloxane Antifoam Is Fed into a 200 m³ Streptomyces Fermentation?

MY-215 is a 15% active polydimethylsiloxane emulsion metered into fermentation broth through a peristaltic or diaphragm pump triggered by headspace foam-sensing electrodes. In a 200 m³ agitated stainless-steel bioreactor producing enzyme intermediates or antibiotic precursors, foam development originates from extracellular protein, mannan, and cell wall fragments released during mid-log growth. Air sparge is typically maintained at 1.0 vvm, and Rushton impeller speed is held between 160 rpm and 220 rpm. Without defoamer feed, foam accumulation in the headspace reduces working volume and can blind vent filters within 6 h. The antifoam is injected at an initial concentration of 5–20 ppm as supplied, and the collapsed foam height is tracked by a headspace capacitance probe aligned with ASTM E2407-04 sparge-tube methodology for relative foam-collapse efficiency.

At silicone loadings below 30 ppm total active equivalent, the impact on the oxygen mass transfer coefficient kLa is usually within the uncertainty of the dissolved-oxygen probe. Above 80 ppm active equivalent, published small-scale agitated-vessel studies report that kLa can decline by more than 10% because polydimethylsiloxane films accumulate at the gas-liquid interface and restrict oxygen diffusion. Published data for this specific configuration in a 200 m³ Streptomyces culture is limited; the threshold should be confirmed by a kLa step test on the production bioreactor. The feed point is therefore placed downstream of the sterile air filter and below the second Rushton impeller, not in the vortex cone, to avoid stripping the emulsion into the condenser. The emulsion is not passable through sterilizing-grade 0.2 µm filters; it is either autoclaved separately in a sealed stainless transfer vessel at 121°C for 30 min or introduced through a pre-sterilized positive-displacement pump cassette. Lot-specific acceptance should include CFU <10, endotoxin load below the site limit, and absence of silicone oil scum on the broth surface after 24 h of settlement.

Small-molecule API isolation trains that exchange ethyl acetate into n-heptane in a 2,000 L vacuum crystallizer use MY-215 at 5–30 ppm of recovered solvent flow to suppress foam carryover into the dry screw pump and chilled condensate trap operating at -5°C. Foam carryover is detected by liquid-level sensors in the condensate drum; carryover greater than 2% of the solvent inventory triggers a metering pulse from the antifoam dosing skid. Because the emulsion contains approximately 85% water, the dosing rate is mass-balanced against the anhydrous ethyl acetate specification for the next crystallization cycle. In a 500 L filtration and drying sequence, silicone residue in the final wet cake is monitored by inductively coupled plasma optical emission spectroscopy after microwave digestion; if the downstream limit for silicon is below 10 ppm in the drug substance, the final rinse protocol includes a hot n-heptane wash to displace silicone film from crystal surfaces.

Aqueous Oral Suspension Deaeration and USP <905> Dosage Uniformity Constraints

High-shear compounding of gum-based oral suspensions entrains air that raises apparent volume and causes fill weight drift on inline piston fillers. MY-215 is introduced at 5–15 ppm of batch weight after the gum dispersion reaches full hydration but before the active pharmaceutical ingredient is added. Deaeration is evaluated by comparing tapped density and fill volume against the formulation master batch. For a 250 mL multi-dose bottle, a 2% volume error can shift the delivered dose outside the acceptance range of USP <905> for low-dose active ingredients. The vessel is mixed with a bottom-entry high-shear disperser at 1,500–2,500 rpm for 10–15 min, then transferred to a vacuum deaeration step at -0.8 bar gauge for residual microbubble removal.

For pharmaceutical final-product applications, the lot must be qualified against the relevant simethicone or silicone emulsion monograph and the silicone content must be declared as an inactive ingredient where required by the registration dossier. Batch records must be maintained under 21 CFR Parts 210 and 211 when the emulsion is used within a finished pharmaceutical manufacturing sequence. The product is not intended for parenteral dosage forms because the emulsion droplet size range can exceed 1 µm and would be removed by 0.2 µm sterilizing filtration. In topical semi-solid manufacturing, addition to the oil phase at 0.1–0.3% w/w prevents air pockets in high-viscosity ointment fill lines without changing the polymorphic form of the active pharmaceutical ingredient.

When Funnel Viscosity Surpasses 60 s on a Water-Based Mud Loop at Surface

Foam generated by lignosulfonate dispersants and partially hydrolyzed polyacrylamide in surface mud systems appears as a funnel viscosity rise above 60 s and a density reduction at the volumetric mixing hopper. MY-215 is injected into the centrifugal pump suction upstream of the shale shaker at 0.05–0.2 vol% of the circulating volume. Defoaming response is checked against ISO 10414-1:2008 funnel viscosity and density, with a return to baseline expected within one full circulation cycle. In high-calcium chloride brine systems above 1.4 SG, the emulsion is pre-diluted 1:5 with fresh water because concentrated chloride brines can destabilize the emulsion and reduce defoaming efficiency.

Hot rolling at 150°F for 16 h is used to assess thermal stability of the treated mud. If the emulsion breaks, free silicone oil can appear as a slick on the mud pit and may reduce API filter cake quality. The addition point is therefore shifted from the active suction pit to a quiet settling section to allow residual foam to collapse before the fluid enters positive-displacement mud pumps. Gas-cut mud is not controlled by silicone antifoam alone; mechanical degassers remain the primary correction for downhole gas influx, and the antifoam only suppresses surface foam generated by mixing.

Produced-water manifolds receiving gas-lifted crude into low-pressure bulk separators experience flashover foam that short-circuits the weir and carries oil into the skimmer header. MY-215 is injected into the water leg upstream of a corrugated plate interceptor at 1–10 ppm of produced-water flow. The injection point is located downstream of the production choke but upstream of the induced gas flotation cells so that foam collapse occurs before gas bubbles attach to oil droplets. Oil-in-water monitors using EPA 1664 or equivalent solvent extraction are used to confirm that discharge concentration remains below the 30 mg/L monthly average required by OSPAR for offshore facilities. Overdosing above 25 ppm can blind oleophilic coalescer packs in polish units and should be avoided if the produced water contains high total suspended solids.

Compatibility with emulsion breakers and scale inhibitors is verified by bottle testing in fresh produced-water samples at 60°C and 1.2 bar backpressure. The silicone antifoam does not replace demulsifier chemistry; it suppresses water-oil interface foam after the bulk emulsion has collapsed. If the system uses a hydrocyclone inlet with a centrifugal pump, the antifoam is added to the pump suction to use impeller shear for dispersion and to prevent foam accumulation inside the hydrocyclone liners.

The principal test anchors for the above pharmaceutical and oilfield unit operations are summarized in the following compliance matrix.

Ultrasonic Compressive Strength Attenuation Tracks Air Entrainment in Cement Slurry

Cement slurry air entrainment is measured by comparing pressurized mud balance density with the density calculated from the mass recipe; a difference greater than 0.02 SG indicates excessive gas hold-up. The 15% active silicone emulsion is introduced at 0.05–0.2 L per 100 kg cement equivalent before the slurry enters the displacement tank. The defoamed slurry is then tested according to API RP 10B-2 / ISO 10426-2:2003 for free water, thickening time, and ultrasonic cement analyzer compressive strength. Foam cell content of 1% by volume can produce a 4–8% reduction in 24 h compressive strength when the slurry is cured at bottomhole static conditions because the air voids act as stress concentrators.

The defoamer is not a substitute for proper mixing energy; the slurry should still be mixed at the API prescribed shear rate for the specified batch duration. In latex-containing slurries, the silicone emulsion may interact with latex stabilizers, so a pilot test is run with the exact field water and cement lot before the main job. The emulsion is added to the mix water rather than the dry cement to avoid balling and non-homogeneous distribution. At bottomhole temperatures above 120°C, published data for this specific emulsion configuration is limited; long-term thermal stability should be confirmed by hot-rolling the mixed water for 12 h at the target temperature before the cement job.

Slickwater frac tanks holding 5,000 bbl during guar hydration exhibit air entrainment from the transfer pump and jet mixer that can create a foam layer pulled into the frac pump suction and reduce proppant-laden fluid density. MY-215 is dosed at 0.01–0.1 gpt into the hydration unit feed line before polymer addition. The defoamer collapses surface foam without interfering with oxidizer breakers used to reduce final viscosity. Because silicone droplets can remain dispersed in the load water and travel into the formation, the lowest effective concentration is determined by a bench-top blender foam test using the actual field water and polymer loading. The test uses a Waring blender at 3,000 rpm for 60 s and records foam half-life; the target is a foam half-life below 10 s after blending stops. Overdosing above 0.2 gpt does not improve foam collapse and may contribute to pore-throat blockage when the produced water is later injected into tight sandstone.